Literature DB >> 8722833

The role of the gastrointestinal tract in hematogenous candidiasis: from the laboratory to the bedside.

G T Cole1, A A Halawa, E J Anaissie.   

Abstract

The gastrointestinal (GI) tract is a frequent source of hematogenous candidiasis in humans. Animal models of GI and hematogenous candidiasis have provided insights into the nature of candidal infection of host mucosal tissue, mechanisms of fungal dissemination to body organs, and features of host response to candidal infections. Biological systems such as these that simulate human candidiasis can be used for testing novel antifungal drugs. We have focused on two murine models of candidiasis with similarities to this fungal disease in humans. The first model simulates a commensal association of Candida albicans with the GI tract of immunocompetent hosts; it has permitted studies of innate and immune cell response to long-term ( > 60 days) infection of the esophageal, gastric, and intestinal mucosa. The second model simulates candidal infection in granulocytopenic patients with invasive candidiasis that originated from sites of colonization in the gut. Both models are well suited for investigating new approaches to prevention and treatment of hematogenous candidiasis. A review of the data on the role of GI candidiasis in hematogenous candidal infections is presented.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8722833     DOI: 10.1093/clinids/22.supplement_2.s73

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  60 in total

Review 1.  Antifungal prophylaxis during neutropenia and immunodeficiency.

Authors:  O Lortholary; B Dupont
Journal:  Clin Microbiol Rev       Date:  1997-07       Impact factor: 26.132

2.  Intestinal lesions associated with disseminated candidiasis in an experimental animal model.

Authors:  K A Andrutis; P J Riggle; C A Kumamoto; S Tzipori
Journal:  J Clin Microbiol       Date:  2000-06       Impact factor: 5.948

3.  Canadian clinical practice guidelines for invasive candidiasis in adults.

Authors:  Eric J Bow; Gerald Evans; Jeff Fuller; Michel Laverdière; Coleman Rotstein; Robert Rennie; Stephen D Shafran; Don Sheppard; Sylvie Carle; Peter Phillips; Donald C Vinh
Journal:  Can J Infect Dis Med Microbiol       Date:  2010       Impact factor: 2.471

4.  Antibiotic exposure as a risk factor for fluconazole-resistant Candida bloodstream infection.

Authors:  Ronen Ben-Ami; Keren Olshtain-Pops; Michal Krieger; Ilana Oren; Jihad Bishara; Michael Dan; Yonit Wiener-Well; Miriam Weinberger; Oren Zimhony; Michal Chowers; Gabriel Weber; Israel Potasman; Bibiana Chazan; Imad Kassis; Itamar Shalit; Colin Block; Nathan Keller; Dimitrios P Kontoyiannis; Michael Giladi
Journal:  Antimicrob Agents Chemother       Date:  2012-02-06       Impact factor: 5.191

5.  Efficacy of surface-generated nitric oxide against Candida albicans adhesion and biofilm formation.

Authors:  Benjamin J Privett; Steven T Nutz; Mark H Schoenfisch
Journal:  Biofouling       Date:  2010-11       Impact factor: 3.209

6.  The Role of the Intestinal Tract As a Source for Transmission of Nosocomial Pathogens.

Authors:  Usha Stiefel; Curtis J Donskey
Journal:  Curr Infect Dis Rep       Date:  2004-12       Impact factor: 3.725

7.  Effect of parenteral antibiotic administration on establishment of intestinal colonization by Candida glabrata in adult mice.

Authors:  Nicole J Pultz; Usha Stiefel; Mahmoud Ghannoum; Marion S Helfand; Curtis J Donskey
Journal:  Antimicrob Agents Chemother       Date:  2005-01       Impact factor: 5.191

8.  Integrin αXβ₂ is a leukocyte receptor for Candida albicans and is essential for protection against fungal infections.

Authors:  Samir Jawhara; Elzbieta Pluskota; Dmitriy Verbovetskiy; Olena Skomorovska-Prokvolit; Edward F Plow; Dmitry A Soloviev
Journal:  J Immunol       Date:  2012-07-27       Impact factor: 5.422

9.  A first Portuguese epidemiological survey of fungaemia in a university hospital.

Authors:  S Costa-de-Oliveira; C Pina-Vaz; D Mendonça; A Gonçalves Rodrigues
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2008-01-19       Impact factor: 3.267

10.  The Pathophysiology and Treatment of Candida Sepsis.

Authors:  Brad Spellberg; John E. Edwards
Journal:  Curr Infect Dis Rep       Date:  2002-10       Impact factor: 3.725

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.